Xcout Intel
92Bio competitors & alternatives
The 12 closest competitors and alternatives to 92Bio among biotechnology companies — ranked by similarity to what 92Bio actually does, not by market-cap band.
Subscribe to see 92Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About 92Bio
92Bio is a clinical-stage biotechnology company headquartered in Hayward, California, that develops next-generation T-cell engaging antibodies for therapeutic treatments.
92Bio at a glance
92Bio is a biotechnology company headquartered in United States. Xcout tracks 12 named people at 92Bio, including Ben Buelow (Chief Executive Officer).
92Bio leadership
- Ben BuelowChief Executive Officer
- Suhasini IyerChief Development Officer
- Andrew BoudreauVP, Informatics
- Antara BanerjeeVP, Discovery Biology
- Ashwin PatelVP, Clinical Operations
- Patrick KoenigVP, Biologics
6 more named people on record for 92Bio, with roles, board committees and tenure — see the full roster →
Top 12 92Bio competitors
Ranked by semantic similarity — how close each company is to 92Bio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Aptevo Therapeutics Inc. is a public, clinical-stage biotechnology company headquartered in Seattle, Washington, focused on developing novel bispecific and trispecific immunotherapies for immuno-oncology.
Similar biotechnology company
Laigo Bio is a biotechnology company that develops targeted protein degradation therapeutics using its proprietary SureTAC platform. The company utilizes bispecific antibodies to direct cell surface targets toward lysosomal degradation, primarily serving the oncology and immunology sectors.
Similar biotechnology company
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
Similar biotechnology company
VelosBio Inc. is a clinical-stage biopharmaceutical company based in California, United States, focused on developing novel antibody-drug conjugates to transform cancer treatment for patients.
Similar biotechnology company
9Bio Therapeutics is a biotechnology company that combines biology, structural engineering, and artificial intelligence to pioneer next-generation biologics for advanced cancers. The company is headquartered in Quebec, Canada.
Similar biotechnology company
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative technology platforms and first-in-class T-cell therapies to access cancer-specific targets.
Biotech
Excalipoint Therapeutics is a clinical-stage biotechnology company headquartered in Shanghai, China. The firm is dedicated to developing next-generation T-cell engager (TCE) therapies and unlocking the therapeutic potential of T-cell based treatments.
Biotech
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
Similar biotechnology company
Amphivena Therapeutics, Inc. is a privately held, clinical-stage biotechnology company based in South San Francisco, California. The company specializes in immuno-oncology, developing a platform of dual-function biologics and selective T cell engagers for the treatment of hematological conditions.
Similar biotechnology company
A2 Biotherapeutics, Inc. is a clinical-stage biotechnology research company headquartered in Agoura Hills, California. The company develops precision T-cell therapies designed to target solid tumors while sparing healthy tissue.
Similar biotechnology company
Trellis Bioscience, Inc. is a clinical-stage biotechnology company located in Redwood City, California, focused on developing antibody-based therapeutics.
Life Sciences
Northern Biologics is a biotechnology company developing antibody-based therapeutics, with a focus on treating cancer and targeting the tumor microenvironment. Its products are intended for oncology patients and clinical partners in the biopharmaceutical sector.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of 92Bio and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for 92Bioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →